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Abstract title: Stress coping behaviour, brain connectivity and LPA1 receptor: Similarities 
and differences between the genetic and the pharmacological approach 
LPA1 receptor is one of the six characterized G protein-coupled receptors (LPA1-6) through 
which lysophosphatidic acid acts as an intercellular signalling molecule. It has been recently 
proposed that this receptor has a key role in controlling depression-like behaviours and in 
the detrimental consequences of stress. Here, we sought to establish the involvement of the 
LPA1 receptor in brain activity after an acute stressor. To this end, we examined behavioural 
despair in mice with a constitutive depletion of the LPA1 receptor (maLPA1-null mice), wild-
type mice and mice receiving one single icv dose of the LPA1 receptor antagonist Ki16425 
or vehicle. Furthermore, the expression of c-Fos protein in stress-related brain areas and the 
corticosterone response following acute stress were examined. Our data indicated that, 
contrary to the knockout model, the antagonism of the LPA1 receptor significantly increased 
immobility in the Forced Swim Test. However, latency to first immobility was reduced in both 
experimental conditions. Immunohistochemistry studies revealed an increased in activity in 
key limbic structures such as medial prefrontal cortex in both the LPA1 antagonist-treated 
mice and maLPA1-null mice, with an interesting opposed effect on hippocampal activity. 
Following acute stress, the sole infusion of Ki16425 in the cerebral ventricle increased 
corticosterone levels. In conclusion, the alteration of LPA1 receptor function, through both 
genetic deletion or pharmacological antagonism, is involved in behavioural despair and 
hyperactivity of brain stress systems, thus contributing to explore specific susceptibility 
mechanisms of stress as targets for therapeutic recovery. 
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